The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects

NCT03663686 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Litapiprant Tablet

Sponsor

Sunshine Lake Pharma Co., Ltd.